Authors:
van den Biggelaar AHJ, Pomat WS
Authors notes:
Vaccine. 2013;31(21):2525-2530
Keywords:
Conjugate vaccine, Haemophilus influenzae, Immunization, Maternal immunization, Newborns, Pneumococcal, Streptococcus pneumoniae
Abstract:
Bacterial conjugate vaccines are based on the principle of coupling immunogenic bacterial capsular polysaccharides to a carrier protein to facilitate the induction of memory T-cell responses.
Following the success of Haemophilus influenzae type b conjugate vaccines in the 1980s, conjugate vaccines for Streptococcus pneumoniae and Neisseria meningitidis infections were developed and proven to be effective in protecting children against invasive disease.
In this review, the use of conjugate vaccines in human newborns is discussed.
Neonatal Haemophilus influenzae type b and pneumococcal conjugate vaccination schedules have been trialed and proven to be safe, with the majority of studies demonstrating no evidence for the induction of immune tolerance.
Whether their neonatal administration also results in an earlier induction of clinical protection in the first 2-3 critical months of life is still to be demonstrated.